Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma. med. app.

Published in: J Neurooncol 2017; 135 (3): 545-552

Exposure